Effect of phentolamine on the increase in brain glycolysis following the intraventricular administration of dibutyryl-3,5-cyclic adenosine monophosphate and sodium fluoride to mice.
D000818:Animals; D001921:Brain / Q000187:drug effects*; D002087:Butyrates / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000242:Cyclic AMP / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004336:Drug Antagonism; D005260:Female; D005459:Fluorides / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006019:Glycolysis / Q000187:drug effects*; D007700:Kinetics; D007773:Lactates / Q000378:metabolism; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology*; D012964:Sodium / Q000494:pharmacology
D002087:Butyrates; D007773:Lactates; D006003:Glycogen; D012964:Sodium; D000242:Cyclic AMP; D005947:Glucose; D005459:Fluorides; D010646:Phentolamine